Logiscreen

ElectroCore Inc

$8.68
Market Cap 70.12M
ROE 836.3%
Gross Margin 87.3%
Debt/Equity -1.7
Current Ratio 1.0
Revenue QoQ 42.6%
EPS QoQ 0.3%
F-Score 2

About

electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-5.39
vs median 35.63
P/B
-14.57
vs median 2.25
ROE
8.36
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics